NO931014L - PHARMACEUTICAL PREPARATION - Google Patents

PHARMACEUTICAL PREPARATION

Info

Publication number
NO931014L
NO931014L NO93931014A NO931014A NO931014L NO 931014 L NO931014 L NO 931014L NO 93931014 A NO93931014 A NO 93931014A NO 931014 A NO931014 A NO 931014A NO 931014 L NO931014 L NO 931014L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
angiotensin
pharmaceutical composition
composition containing
receptor antagonist
Prior art date
Application number
NO93931014A
Other languages
Norwegian (no)
Other versions
NO931014D0 (en
Inventor
Werner Mederski
Dieter Dorsch
Rolf Gericke
Manfred Baumgarth
Pierre Schelling
Rolf Bergmann
Norbert Beier
Ingeborg Lues
Klaus-Otto Minck
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO931014D0 publication Critical patent/NO931014D0/en
Publication of NO931014L publication Critical patent/NO931014L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Et farmasøytisk preparat inneholdende en kaliumkanalaktivator og en angiotensin-Il-reseptorantagonist.A pharmaceutical composition containing a potassium channel activator and an angiotensin II receptor antagonist.

NO93931014A 1992-03-20 1993-03-19 PHARMACEUTICAL PREPARATION NO931014L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4209071A DE4209071A1 (en) 1992-03-20 1992-03-20 PHARMACEUTICAL PREPARATION

Publications (2)

Publication Number Publication Date
NO931014D0 NO931014D0 (en) 1993-03-19
NO931014L true NO931014L (en) 1993-09-21

Family

ID=6454609

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93931014A NO931014L (en) 1992-03-20 1993-03-19 PHARMACEUTICAL PREPARATION

Country Status (13)

Country Link
EP (1) EP0561357A1 (en)
JP (1) JPH0648961A (en)
KR (1) KR930019215A (en)
CN (1) CN1076357A (en)
AU (1) AU3528593A (en)
CA (1) CA2091942A1 (en)
DE (1) DE4209071A1 (en)
HU (1) HUT63764A (en)
MX (1) MX9301546A (en)
NO (1) NO931014L (en)
PL (1) PL298159A1 (en)
TW (1) TW237384B (en)
ZA (1) ZA931984B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5574049A (en) * 1994-07-22 1996-11-12 Sandoz Ltd. 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrans

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3915236A1 (en) * 1989-05-10 1990-11-15 Merck Patent Gmbh PHARMACEUTICAL PREPARATION
DE4004268A1 (en) * 1990-02-13 1991-08-14 Merck Patent Gmbh PHARMACEUTICAL PREPARATION

Also Published As

Publication number Publication date
JPH0648961A (en) 1994-02-22
EP0561357A1 (en) 1993-09-22
NO931014D0 (en) 1993-03-19
PL298159A1 (en) 1993-10-18
DE4209071A1 (en) 1993-09-23
TW237384B (en) 1995-01-01
CN1076357A (en) 1993-09-22
HU9300796D0 (en) 1993-06-28
MX9301546A (en) 1993-09-01
AU3528593A (en) 1993-09-23
KR930019215A (en) 1993-10-18
HUT63764A (en) 1993-10-28
ZA931984B (en) 1993-10-19
CA2091942A1 (en) 1993-09-21

Similar Documents

Publication Publication Date Title
NO981501D0 (en) Dimer-selective RXR modulators and methods for their use
NO962474D0 (en) Cementing Mixture
IL128003A0 (en) Therapeutic multispecific compounds comprised of anti-fcalpha receptor antibodies
NO306398B1 (en) Substituted N- (indole-2-carbonyl) glycinamides, their use, intermediate and pharmaceutical composition
IS1846B (en) Substituted N- (indole-2-carbonyl) -b-alaninamide, their use and drug formulations
NO20004743L (en) Pharmaceutical compositions containing irbesartan and a diuretic
NO974337D0 (en) Storage stable drug forms
NO941161D0 (en) Fly ash cementing compositions and methods
FI961251L (en) Human metabotropic glutamate receptor subtypes (HMR4, HMR6, HMR7) and their associated DNA compounds
NO933475D0 (en) SETTING RETARDING ADDITIVES, COMPOSITIONS AND PROCEDURES FOR CEMENT
NO981146D0 (en) Transcytotic agents and enhancers for drug delivery
NO931496L (en) Cuttings cement compositions and methods for using them
DE69429861D1 (en) Endothelin receptor Antagonist
NO933447D0 (en) KNOT PLATE COMPOSITION FOR AN UNDERWATER CONSTRUCTION
DE69331175D1 (en) Interleukin-2 receptor gamma chain
BR9200323A (en) FORMULATION OF CURABLE TIOL-ENO, AND ITS COMPOSITION
DE59706450D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING LORNOXICAM AND A DINATRIUM SALT OF EDTA
FI972988A0 (en) Methods and pharmaceutical compositions using desmethylselegiline
FR2767526B1 (en) BI-AROMATIC COMPOUNDS LINKED BY A HETEROETHYNYLENE RADICAL AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM
NO931014L (en) PHARMACEUTICAL PREPARATION
TR199800152T1 (en) Endothelin Receptor Antagonists
NO20000107L (en) New mixture
NO990322D0 (en) Pharmaceutical mixture containing a 5HT2c antagonist and a D2 antagonist
DE69526738D1 (en) Endothelin receptor Antagonist
IT1263804B (en) PYRIMIDINONIC DERIVATIVES MELT WITH NITROGEN HETEROCYCLES ACTIVATED IN II ANTAGONIST